Join StemBioSys for this webinar on rapid maturation of plated cardiomyocytes


Date: Thursday, July 15, 2021
Time: 4:00 PM 5:00 PM

Hosted by:

Travis J. Block, PhD, Chief Technology Officer, StemBioSys

Todd Herron, PhD, Cardiovascular Regeneration Core Director and Associate Research Scientist, Molecular and Integrative Physiology and Internal Medicine, University of Michigan Medical School and a founder of Cartox

iPSC-derived cardiomyocytes grown on CELLvo™ Matrix Plus rapidly and spontaneously mature and behave as they do in the human body. StemBioSys CELLvo™ Matrices are easy to use and fit into existing workflows. iPSC-derived somatic cells require an appropriate ECM for biologically-relevant function and CELLvo™ Matrices provide an appropriate microenvironment for iPSC-derived cells to achieve maturity in vitro.

CELLvo Plating Protocol Available from FUJIFILM Cellular Dynamics

iCell® Cardiomyocytes2 are cardiac myocytes derived from human induced pluripotent stem cells (iPSC). These cardiomyocytes have been optimized for faster recovery from cryopreservation and can be used in a myriad of functional applications.
A recent article by Block et al. in Nature Scientific Reports indicates that iCell Cardiomyocytes2 have enhanced functional and structural benefits following culture on CELLvo™ Matrix Plus plates for seven days. The available FCDI application protocol details the steps for plating iCell Cardiomyocytes2 on the CELLvo Matrix Plus plates.

Sign Up to See the FCDI Application Protocol: Plating iCell Cardiomyocytes2 on CELLvo™ MATRIX PLUS: